Pharicin A, a novel natural ent-kaurene diterpenoid, induces mitotic arrest and mitotic catastrophe of cancer cells by interfering with BubR1 function

Pharicin A, a novel natural ent-kaurene diterpenoid, induces mitotic arrest and mitotic catastrophe of cancer cells by interfering with BubR1 function
复制标题

Pharicin A 是一种新型天然对映贝壳杉烯二萜类化合物,通过干扰 BubR1 功能诱导癌细胞有丝分裂停滞和有丝分裂灾难

DOI:
10.4161/cc.9.14.12406
复制
发表时间:
2010-07
期刊:
影响因子:
4.3
通讯作者:
Xiao, Wei-Lie
Xiao, Wei-Lie
中科院分区:
生物学3区
文献类型:
--
作者:
Chen, Guo-Qiang;Huang, Ying;Sun, Han-Dong;Lin, Qi-Shan;Wu, Ying-Li;Dai, Wei;Zhao, Yong;Xu, Han-Zhang;Xiao, Wei-Lie

文献摘要

参考文献

被引文献

相似文献

在这项研究中,我们报告了一个新的ent-kaurene二萜称为pharicin A,这最初是从干燥香茶菜,一种多年生灌木,经常在中国民间医药用于肿瘤治疗分离的功能特性。Pharicin A诱导白血病和实体瘤衍生细胞的有丝分裂停滞,通过其形态、DNA含量和有丝分裂标记物分析鉴定。Pharicin A诱导的有丝分裂阻滞与染色体未对齐、BubR 1异常定位和纺锤体检查点激活失调有关。Pharicin A在体外直接与BubR 1结合,这与体内姐妹染色单体过早分离相关。Pharicin A还诱导紫杉醇抗性Jurkat和U2 OS细胞中的有丝分裂停滞。结合,我们的研究强烈表明,pharicin A代表了一类新的小分子化合物,能够干扰有丝分裂进程和启动有丝分裂灾难,值得进一步的临床前和临床研究癌症药物开发。
In this study, we report the functional characterization of a new ent-kaurene diterpenoid termed pharicin A, which was originally isolated from Isodon xerophilus, a perennial shrub frequently used in Chinese folk medicine for tumor treatment. Pharicin A induces mitotic arrest in leukemia and solid tumor-derived cells identified by their morphology, DNA content, and mitotic marker analyses. Pharicin A-induced mitotic arrest is associated with unaligned chromosomes, aberrant BubR1 localization, and deregulated spindle checkpoint activation. Pharicin A directly binds to BubR1 in vitro, which is correlated with premature sister chromatid separation in vivo. Pharicin A also induces mitotic arrest in paclitaxel-resistant Jurkat and U2OS cells. Combined, our study strongly suggests that pharicin A represents a novel class of small molecule compounds capable of perturbing mitotic progression and initiating mitotic catastrophe, which merits further preclinical and clinical investigations for cancer drug development.
DOI: 10.1016/s1040-8428(02)00105-1
发表时间: 2002-12
期刊: Critical reviews in oncology/hematology
影响因子: --
作者:
H. Lück;H. Roché
通讯作者: H. Lück;H. Roché
DOI: 10.1371/journal.pbio.0030086
发表时间: 2005-03
期刊: PLoS biology
影响因子: 9.8
作者:
McGuinness BE;Hirota T;Kudo NR;Peters JM;Nasmyth K
通讯作者: Nasmyth K
DOI: 10.1074/jbc.272.45.28646
发表时间: 1997-11-07
影响因子: 4.8
作者:
Bin, OY;Pan, HQ;Dai, W
通讯作者: Dai, W
DOI: 10.1038/sj.onc.1202983
发表时间: 1999-10-28
期刊: ONCOGENE
影响因子: 8
作者:
Bin, OY;Li, WQ;Dai, W
通讯作者: Dai, W
DOI: 10.1016/s0092-8674(03)00475-6
发表时间: 2003-07-11
期刊: CELL
影响因子: 64.5
作者:
Mao, YH;Abrieu, A;Cleveland, DW
通讯作者: Cleveland, DW